
LifeStance Health rose 115.9% from $6.18 to $13.34, ahead of the S&P 500's +9.7%. Its worst day was May 8 (−13.0%), and its low came Nov 20 at $6.18.
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.03 missed the $0.05 estimate on $382.2M revenue (est. $378.0M); Q1 revenue guidance of $380.0M–$400.0M against the $381.4M consensus.
+3.8% · S&P 500 +0.8%
Story events cover the past 12 months · Times ET
EPS of $0.04 missed the $0.05 estimate on $403.5M revenue (est. $386.5M); Q2 revenue guidance of $405.0M–$425.0M against the $399.6M consensus.
+20.2%, the year's best day · S&P 500 −0.3%
LifeStance Health shares rose 9.5%, while the S&P 500 rose 1.7%.
+9.5% · S&P 500 +1.7%
EPS of $0.06 missed the $0.07 estimate on $435.4M revenue (est. $414.4M); Q3 revenue guidance of $420.0M–$440.0M against the $417.7M consensus.
+2.8% · S&P 500 −0.2%
EPS of $0.06 missed the $0.07 estimate on $455.9M revenue (est. $431.0M); Q4 revenue guidance of $446.0M–$466.0M against the $438.0M consensus.
−5.5% · S&P 500 −4.4%
Where it ended: a close of $13.34 on Nov 19, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.09, revenue est. $456.8M).
Nothing in the past 12 months.
All LFST dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LFST and SPY from Benzinga historical bars. Not investment advice.